Vistagen to report second quarter financial results and host corporate update conference call on november 9, 2023

South san francisco, calif.--(business wire)--vistagen (nasdaq: vtgn), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression, and other central nervous system (cns) disorders, today announced it will host a conference call and webcast on thursday, november 9, 2023, at 2:00 p.m. pacific time (5:00 p.m. eastern time) to provide a corporate update and report results for its fiscal year 2024 second quarter ended s.
VTGN Ratings Summary
VTGN Quant Ranking